FDA authorizes sale of Zyn nicotine pouches, saying public health benefits outweigh risk
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned 119 retailers to stop selling Zyn to underage people, and the company was ordered to pay $1.2 million last year for violating Washington, D.C.’s smokeless tobacco ban.
Altria Group stock outperformed the S&P 500 over the past year (total return), something you don't hear about so often. See ...
Officials proposed limiting the amount of nicotine to make cigarettes less addictive, but it's unclear if the incoming ...
Philip Morris Intl. expands into cannabis via Avicanna partnership, focusing on medical research and innovation: How this ...
Despite the seemingly restrictive nature of the FDA's proposed ruling, I remain highly optimistic about the resilience and ...
Shares of Altria Group, Inc. (NYSE:MO – Get Free Report) have received an average recommendation of “Hold” from the eight ...
24/7 Wall St. on MSN10d
Altria Just Paid Investors: Here’s How Much They ReceivedAltria Group Inc. (NYSE: MO) is rewarding its shareholders once again with a quarterly dividend of $1.02, payable on Friday, ...
In a report released today, Eric Serotta from Morgan Stanley maintained a Hold rating on Altria Group (MO – Research Report), with a price ...
The company and industry continued to face competition from the growth of illicit e-vapor products and more discretionary income pressures on adult tobacco consumers. However, Altria's price hikes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback